FindTrial
Sign In

Study on assessment of psychotropic drug prescribing pattern in schizophrenic patients

Assessment of psychotropic drug prescribing pattern in patients with schizophrenia: A Prospective observational study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/09/036862
Enrollment
75
Registered
2021-09-27
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F209- Schizophrenia, unspecified

Interventions

Intervention1: NIL: NIL

Sponsors

NIL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients diagnosed with schizophrenia according to the diagnostic and statistical Manual of Mental Disorders, fourth edition or the International Classification of Disease, 10th Revision (ICD-10). Patients aged 18 years and above Patients treated with psychotics drugs on inpatient at the hospital.

Exclusion criteria

Exclusion criteria: Patients with major medical illness. Patients not willing to participate

Design outcomes

Primary

MeasureTime frame
Analysis of prescribing pattern of psychotropic drugs will serve as a baseline data to help clinicians to implement safe and cost effective treatment to the patients.Timepoint: 8 months—

Secondary

MeasureTime frame
This study will provide a framework for reasonable prescribing and also reduce polypharmacy by following the guidelinesTimepoint: 8 months—

Countries

India

Contacts

Public ContactDr Satheesh Rao

NGSM Institute of Pharmaceutical Sciences

Junojoel@nitte.edu.in9480470727

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026